Gov. Bush lauds research institutions’ role in diverse economy
Sun-Sentinel - 2 hours, 4 minutes ago
WEST PALM BEACH — Cutting taxes, rewarding businesses with incentives and luring the biotechnology industry to Florida are key to diversifying the state’s economy, Gov. Jeb Bush told a group of researchers, venture capitalists and biotech executives Tuesday.Save to My Web
UC studies hunger hormone
Cincinnati Enquirer - Feb 21 5:11 AM
Low levels of the so-called “hunger hormone” that regulates food intake and body weight might play a role in memory loss, according to a study co-authored by researchers at the University of Cincinnati.Save to My Web
Minnelli Step-mother To Stay Put
ContactMusic - Feb 21 6:19 AM
LATEST: Singing legend LIZA MINNELLI sold her late father’s Beverly Hills, California, estate with her elderly stepmother still inside the mansion.Save to My Web
FDA Accepts Eisai’s SNDA Application For ARICEPT In The Treatment Of Severe Alzheimer’s Disease
Medical News Today - Feb 20 12:02 AM
Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO Haruo Naito) and Eisai Inc. (Headquarters: Teaneck, NJ, Chairman and CEO Hajime Shimizu) announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for ARICEPT (donepezil HCl tablets) for treatment of severe Alzheimer’s Disease… click link for more info.Save to My Web
69-Year-Old Alzheimer’s Patient Reported Missing
WRAL-TV 5 Raleigh - Feb 20 7:21 PM
Investigators in Wilson County are searching for a missing Alzheimer’s patient who is in poor health.Save to My Web
Samaritan Aims to Compete in Alzheimer’s Drug Market
[Press Release] Business Wire via Yahoo! Finance - Feb 21 4:00 AM
LAS VEGAS—-Feb. 21, 2006–Samaritan Pharmaceuticals Inc. : Lead Discovery in Announcing Breaking Journal Articles Features Neuroscience Article Discussing the Spirostenol Compound SP-233 to Be Of Special Interest Samaritan Has In-Licensed Cited Alzheimer’s Drug SP-233 Preclinical Trials Continue to Show Promise Expect to File for Alzheimer’s IND with FDA Mid-YearSave to My Web